New clues to the development of Parkinson's disease: Copper leads to protein aggregation - Suspicious metal
New hopes for disease modification in Parkinson's Disease - ScienceDirect
IJMS, Free Full-Text
PDF) Alpha synuclein post translational modifications: potential targets for Parkinson's disease therapy?
Pharmaceutics, Free Full-Text
Neuronal haemoglobin induces loss of dopaminergic neurons in mouse Substantia nigra, cognitive deficits and cleavage of endogenous α-synuclein
Frontiers Parkinson's Disease: A Nanotheranostic Approach Targeting Alpha- Synuclein Aggregation
A Peptide Approach to Reducing alpha-Synuclein in Parkinson's Disease
Pharmaceutics, Free Full-Text
PDF] The Qualification of an Enrichment Biomarker for Clinical Trials Targeting Early Stages of Parkinson's Disease
New hopes for disease modification in Parkinson's Disease - ScienceDirect
IJMS, Free Full-Text
Alpha-Synuclein: Biomarker for Parkinson's Disease, It's Estimation Methods, and Targeted Medicinal Therapies